CVS Health (CVS) FY2025 10-K Annual Report
CVS Health (CVS) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 10, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
CVS Health FY2025 10-K Analysis
Business Overview
- • Core business risk focus on compliance with extensive laws, regulations, and contractual requirements in healthcare sectors
- • Increased litigation exposure due to vertical integration strategy and expanded healthcare services
- • Ongoing costly class action, qui tam, securities, and derivative litigation with potential high damages, not fully insured
- • Heightened regulatory audits, inspections, government inquiries, and legal proceedings inside and outside U.S.
- • Insurance coverage limits highlighted with risks of unavailable or insufficient insurance, especially for punitive damages
Management Discussion & Analysis
- • No revenue or profitability data disclosed in this MD&A section
- • Market valuation risk: $3.6B fair value decline in long-term debt with 100bp rate increase; no impact on operations
- • Interest rate sensitive investment net fair value decline approx. $765M, recorded as unrealized loss in equity
- • No material foreign currency or commodity derivative exposures as of Dec 31, 2025
- • Cybersecurity risks ongoing; no material impact on operations; significant resources allocated to risk mitigation
Risk Factors
- • Opioid litigation risk: $320 million accrual increase for ongoing opioid litigation matters in 2025
- • Geopolitical/macroeconomic exposure: Medicare Advantage segment served 37 million people, sensitive to CMS policy changes
- • Supply chain vulnerability: Reliance on pharmaceutical pricing negotiations through group purchasing organization for drug cost management
- • Competitive risk: Health Services segment faces disruption from Signify Health and Oak Street Health in value-based primary care
- • Financial risk: $5.7 billion goodwill impairment in Health Care Delivery reporting unit in 2025 impacting operating income
CVS Health FY2025 Key Financial MetricsXBRL
Revenue
$402.1B
▲ +7.8% YoY
Net Income
$1.8B
▼ -61.7% YoY
Operating Margin
1.2%
▼ -113bp YoY
Net Margin
0.4%
▼ -80bp YoY
ROE
2.4%
▼ -376bp YoY
Total Assets
$253.5B
▲ +0.1% YoY
EPS (Diluted)
$1.39
▼ -62.0% YoY
Operating Cash Flow
$10.6B
▲ +16.8% YoY
Source: XBRL data from CVS Health FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on CVS Health
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.